Technical Analysis for ETON - Eton Pharmaceutcials, Inc.

Grade Last Price % Change Price Change
grade F 7.5 3.02% 0.22
ETON closed up 3.02 percent on Wednesday, November 25, 2020, on 61 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Up
Historical ETON trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
20 DMA Support Bullish 3.02%
Bollinger Band Squeeze Range Contraction 3.02%
50 DMA Resistance Bearish 0.81%
20 DMA Support Bullish 0.81%
Bollinger Band Squeeze Range Contraction 0.81%
20 DMA Support Bullish 1.90%
Bollinger Band Squeeze Range Contraction 1.90%
Narrow Range Bar Range Contraction 1.90%
Older End-of-Day Signals for ETON ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above 50 DMA about 8 hours ago
50 DMA Support about 8 hours ago
Rose Above 10 DMA about 10 hours ago
10 DMA Support about 10 hours ago
Gap Up Partially Closed about 10 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical product using the U.S. Food and Drug Administration's 505(b)(2) regulatory pathway. It primarily focuses on liquid products, including injectable, oral liquid, and ophthalmic products. The company is developing DS-300, an injectable nutrition product candidate; EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-103, an oral liquid product candidate; DS-100, an injectable product candidate for use in pain management; DS-200, an injectable parenteral nutrition product candidate; ET-101, an oral liquid product for use in seizure control; ET-102, an oral liquid product for use as a muscle relaxant; and CT-100, a synthetic corticotropin therapeutic candidate that mimics the amino acid chain of H.P. Acthar Gel. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Medicine Health Pharmaceutical Pain Pharmaceuticals Policy Pain Management Ophthalmic Products Allergic Conjunctivitis Liquid Products Pharmaceutical Product Seizure

Is ETON a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.12
52 Week Low 2.5
Average Volume 438,877
200-Day Moving Average 6.01
50-Day Moving Average 7.54
20-Day Moving Average 7.24
10-Day Moving Average 7.39
Average True Range 0.40
ADX 9.25
+DI 21.72
-DI 17.18
Chandelier Exit (Long, 3 ATRs ) 7.21
Chandelier Exit (Short, 3 ATRs ) 7.72
Upper Bollinger Band 7.72
Lower Bollinger Band 6.76
Percent B (%b) 0.77
BandWidth 13.19
MACD Line -0.01
MACD Signal Line -0.04
MACD Histogram 0.0351
Fundamentals Value
Market Cap 181.6 Million
Num Shares 24.2 Million
EPS -3.07
Price-to-Earnings (P/E) Ratio -2.44
Price-to-Sales 233.75
Price-to-Book 24.83
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.04
Resistance 3 (R3) 8.03 7.83 7.95
Resistance 2 (R2) 7.83 7.70 7.84 7.92
Resistance 1 (R1) 7.67 7.61 7.57 7.68 7.89
Pivot Point 7.47 7.47 7.43 7.48 7.47
Support 1 (S1) 7.31 7.34 7.21 7.32 7.11
Support 2 (S2) 7.11 7.25 7.12 7.08
Support 3 (S3) 6.95 7.11 7.05
Support 4 (S4) 6.96